Skip to main content
. 2019 Nov;113(5):948–957. doi: 10.5935/abc.20190190

Table 5.

Patients from group 2 on triple therapy

Antithrombotic therapy Group 2 - New onset AF
Aspirin + Clopidogrel + Vitamin K antagonists 10.2
Aspirin + Clopidogrel + NOACs 5.9
Aspirin + Ticagrelor/Prasugrel + Vitamin K antagonists 0
Aspirin + Ticagrelor/Prasugrel + NOACs 0
Total 16.1

Values are percentage (%). AF: atrial fibrillation; ACE inhibitors: angiotensin conversion enzyme inhibitors; ARB: angiotensin receptor blockers; NOAC: non vitamin K anticoagulant.